open-burger-menu
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
📈 NEW Report: Abortions, Tax Funding UP at Planned Parenthood >>
Search Icon
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

close-panel
Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Research Type:

Or Choose Category
End of Life
Life & the Law
Maternal & Public Health
Abortion
Fetal Tissue, Stem Cells & Bioethics
Fetal Development
Abortion Drugs
Trending Research

Sort 1464 results by:

Filter results further
Filter Applied. Clear All

Latest Posts

October 6, 2026 A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review October 6, 2026 Inside The Government Decision That Opened Up Abortion Pill Floodgates Inside The Government Decision That Opened Up Abortion Pill Floodgates October 6, 2026 Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Research Type
Publication Type
By State
See All
By Author
See All
Reset All Filters

Did You Know ?

Did You Know ?

In the fourth week, the embryonic heart starts beating. The neural tube, which becomes the brain and spinal cord, forms. At this point, a woman has likely only been aware of her pregnancy for one week.

Did You Know ?

In the seventh week after conception, networks of neurons produce brain waves that have been recorded as early as 6 ½ weeks after conception. The embryo spontaneously moves his arms, hands, and legs, and may even hiccup. The embryo’s heart now has all four chambers.

Did You Know ?

By the seventeenth and eighteenth week after gestation, the fetus shows a clear response to pain in multiple studies, and at least one brain pathway is mature enough to create a perception of pain. The fetus also practices breathing, crying, and breastfeeding in the womb. The fetal heart has beat over 20 million times and circulates about 55 quarts of blood per day.

Did You Know ?

In the eighth month of pregnancy the fetal brain is ready to learn! At 32 weeks after conception, neurons are creating 40,000 new connections, called synapses, every second! With repeated exposures, the fetus can learn flavors, nursery rhymes, songs, and even words that she will recognize after birth!

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review
Latest Research / Abortion Drugs

A Critical Analysis of the FDA’s 2021 Mifepristone REMS Modification Rationale Review

This paper critically analyzes the FDA's 2021 REMS Review leading to the removal of the in-person dispensing requirement for mifepristone.

Zachary Sluzala,… Ingrid Skop,…
October 6, 2026
Inside The Government Decision That Opened Up Abortion Pill Floodgates
Latest Research / Abortion Drugs

Inside The Government Decision That Opened Up Abortion Pill Floodgates

The decision "fell well short" of the FDA's standards.

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone
Latest Research / Life & the Law

Unintended Consequences of the FDA’s 2021-2023 Risk Evaluation and Mitigation Strategy (REMS) Changes to Mifepristone

This paper critically analyzes the FDA's 2021 literature review that served as the basis for its controversial decision to remove…

Ingrid Skop,…
October 6, 2026
Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement
Latest Research / Abortion Drugs

Peer-Reviewed Article: FDA Lacked Evidence to Drop In-Person Abortion Drug Requirement

A new peer-reviewed article on the Food and Drug Administration’s (FDA) 2021 complete review of mifepristone’s Risk Evaluation and Mitigation…

charlotte-lozier-institute Charlotte Lozier Institute
October 6, 2026
Abortion Reporting: Kentucky (2025)
Latest Research / Maternal & Public Health

Abortion Reporting: Kentucky (2025)

In 2025, five brick-and-mortar abortions were reported in Kentucky by the state’s Cabinet for Health and Family Services. The data…

Elyse Gaitan Mia Steupert,…
October 5, 2026
A doctor in a white coat uses a digital tablet to show information to a patient across a desk. The patient's hands are clasped.
Abortion Drugs

New Study Finds Informed Consent Gaps for Abortion Drugs as Women Report Unexpected Pain, Bleeding

A new peer-reviewed article by the Charlotte Lozier Institute (CLI) identifies informed consent gaps for abortion drugs as women report unexpected pain, bleeding, and mental health impacts

charlotte-lozier-institute Charlotte Lozier Institute
June 10, 2026
A pregnant woman stands indoors by a window with white curtains, gently holding her belly and looking outside. Natural light fills the room, reflecting hope for improving interventions for substance use disorder in pregnant women.
Maternal & Public Health

Substance Use Disorder in Pregnant Women: State of the Problem, Treatment, and Recommendations for Improving Interventions

This paper explores the extent of the problem of substance abuse during pregnancy, best practices for treatment, and some recommendations for improvement.

Ben Cook, Ph.D.
June 9, 2026
A large crowd gathers in front of the U.S. Supreme Court building in Washington, D.C., under a clear blue sky, as discussions on trends and the Dobbs decision unfold amid visible columns and flags.
Life & the Law

What Should We Expect in Maternal Mortality Trends Due to the Dobbs Decision?

This paper examines claims that pro-life laws in effect post-Dobbs would increase maternal mortality rates.

Ingrid Skop, M.D.,…
June 4, 2026
Row of parked American cars in a parking lot, photographed from the rear at sunset, with warm sunlight reflecting off the SUVs.
Life & the Law

Fact of Life: American Cars (and Their Drivers) Exhibit Decidedly More Pro-life than Pro-choice Views

Pro-life license plates are currently available in the District of Columbia and 32 states, while only four states offer a pro-choice plate option. In states that have both options, pro-life plates greatly out-sell their pro-abortion counterparts.

Jeanneane Maxon, J.D.
June 2, 2026
Maternal & Public Health

Abortion Reporting: Utah (2024)

Utah’s 2024 abortion data was published on the state’s new Abortion Dashboard. The state also provided drug-induced abortion data upon request. The data reveals that reported abortions increased from 2023 to 2024. However, Utah’s new Abortion Dashboard excluded several categories of data previously provided to CLI upon request and/or included in the state’s published abortion reports.

Mia Steupert, M.A. Elyse Gaitan
June 1, 2026
Maternal & Public Health

Abortion Reporting: Vermont (2024)

Vermont’s 2024 abortion statistics were published online as part of the state’s full vital statistics report in April 2026. The report is available on the Vermont Department of Health website and shows that Vermont abortions decreased in 2024. The data published by the state does not include the total number of abortions obtained by Vermont residents out of state or the number of self-managed abortions on women outside of the healthcare system. It is also unlikely that the report contains the total number of mail-order abortion drugs obtained by Vermont residents prescribed by licensed abortion providers in Vermont and in other states.

Elyse Gaitan Mia Steupert, M.A.
June 1, 2026
Maternal & Public Health

Abortion Reporting: Massachusetts (2024)

Massachusetts’ 2024 abortion statistics were published in December 2025 by the Massachusetts Department of Public Health (MDPH). Reported abortions in Massachusetts more than doubled from 2023 to 2024. This data does not include the total number of abortions obtained by Massachusetts residents out of state or the number of self-managed abortions performed on women outside of the formal healthcare system.

Mia Steupert, M.A. Elyse Gaitan
June 1, 2026
Maternal & Public Health

Abortion Reporting: Montana (2024)

Montana’s 2024 vital statistics report, which contains the state’s abortion data, was published by the Montana Department of Public Health Services (MDPH) in March 2026. The report shows that reported Montana abortions decreased from 2023 to 2024. The data published by the state does not include the total number of abortions obtained by Montana residents out of state or the number of self-managed abortions on women outside of the healthcare system. It is also unlikely that the report contains the total number of mail-order abortion drugs obtained by Montana residents prescribed by licensed providers in Montana or other states.

Mia Steupert, M.A. Elyse Gaitan
June 1, 2026

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image